Degradation of human α- And β-defensins by culture supernatants of porphyromonas gingivalis strain 381

Journal of Innate Immunity

Volumn 1, Issue 2, 2009, Pages 118-122

  Carlisle, M D ^a   Srikantha, R N ^b   Brogden, K A ^a,b  

^a Department of Periodontics ^*  (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Defensins; Gingipains; Porphyromonas gingivalis; Proteases

Indexed keywords

ALPHA DEFENSIN; BACTERIAL ENZYME; BETA DEFENSIN; PROTEINASE; BIOLOGICAL FACTOR; PEPTIDE HYDROLASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; INNATE IMMUNITY; NONHUMAN; OBSERVATION; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SUPERNATANT; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM;

ALPHA-DEFENSINS; BETA-DEFENSINS; BIOLOGICAL FACTORS; HUMANS; PEPTIDE HYDROLASES; PORPHYROMONAS GINGIVALIS;

EID: 70350461325     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000181015     Document Type: Article

References (35)

1. Offenbacher S: Periodontal diseases: pathogenesis. Ann Periodontol 1996; 1:821-878.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr: Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25:134-144.
3. Ledder RG, Gilbert P, Huws SA, Aarons L, Ashley MP, Hull PS, McBain AJ: Molecular analysis of the subgingival microbiota in health and disease. Appl Environ Microbiol 2007; 73: 516-523.
4. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, De-whirst FE: Bacterial diversity in human subgingival plaque. J Bacteriol 2001; 183:3770-3783.
5. Lamont RJ, Jenkinson HF: Life below the gum line: pathogenic mechanisms of Por-phyromonas gingivalis . Microbiol Mol Biol Rev 1998; 62:1244-1263.
6. Progulske-Fox A, Kozarov E, Dorn B, Dunn W Jr., Burks J, Wu Y: Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system. J Periodontal Res 1999;34:393-399.
7. Potempa J, Travis J: Porphyromonas gingivalis proteinases in periodontitis, a review. Acta Biochim Pol 1996; 43:455-465.
8. Banbula A, Mak P, Bugno M, Silberring J, Dubin A, Nelson D, Travis J, Potempa J: Prolyl tripeptidyl peptidase from Porphyromonas gingivalis : a novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem 1999; 274: 9246-9252.
9. Banbula A, Bugno M, Goldstein J, Yen J, Nelson D, Travis J, Potempa J: Emerging family of proline-specific peptidases of Porphyromonas gingivalis : purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun 2000;68:1176-1182.
10. Travis J, Pike R, Imamura T, Potempa J: Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res 1997;32:120-125.
11. Imamura T: The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003; 74:111-118.
12. Mezyk-Kopec R, Bzowska M, Potempa J, Bzowska M, Jura N, Sroka A, Black RA, Be-reta J: Inactivation of membrane tumor necrosis factor α by gingipains from Porphyromonas gingivalis . Infect Immun 2005; 73: 1506-1514.
13. Yun PL, Decarlo AA, Chapple CC, Hunter N: Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. Infect Immun 2005; 73:1386-1398.
14. Sroka A, Sztukowska M, Potempa J, Travis J, Genco CA: Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (gingipains) of Porphyromonas gingivalis . J Bacteriol 2001;183:5609-5616.
15. Devine DA, Marsh PD, Percival RS, Ranga-rajan M, Curtis MA: Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 1999; 145: 965-971.
16. Bissell J, Joly S, Johnson GK, Organ CC, Dawson D, B. McCray PB Jr, Guthmiller JM: Expression of ß-defensins in gingival health and in periodontal disease. J Oral Pathol Med 2004; 33:278-285.
17. Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, Valore EV, Ganz T, Anderson GM, Weinberg A: Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 2001; 36: 285-294.
18. Dunsche A, Acil Y, Dommisch H, Siebert R Schroder JM, Jepsen S: The novel human ß-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 2002; 110:121-124.
19. Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A: Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin Chem 2007;53:757-765.
20. Diamond DL, Kimball JR, Krisanaprakornkit S, Ganz T, Dale BA: Detection of ß-defensins secreted by human oral epithelial cells. J Immunol Methods 2001;256:65-76.
21. Pisano E, Cabras T, Montaldo C, Piras V, Inzitari R, Olmi C, Castagnola M, Messana I: Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur J Oral Sci 2005; 113:462-468.
22. Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, Burnell KK, Srikan-tha RN, Xiao X, Bélanger M, Progulske-Fox A, Cavanaugh JE, Guthmiller JM, Johnson GK, Joly S, Kurago ZB, Dawson DV, Brogden KA: Human ß-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis , and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol 2008, E-pub ahead of print.
23. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004;22: 181-215.
24. Joly S, Maze C, McCray PB Jr, Guthmiller JM: Human ß-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004; 42: 1024-1029.
25. Travis J, Banbula A, Potempa J: The role of bacterial and host proteinases in periodontal disease. Adv Exp Med Biol 2000; 477: 455-465.
26. Curtis MA, Aduse-Opoku J, Rangarajan M: Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001; 12:192-216.
27. Ji S, Hyun J, Park E, Lee BL, Kim KK, Choi Y: Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 2007;42: 410-419.
28. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M: Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides,ß-defen-sins and LL37, produced by human epithelial cells. J Antimicrob Chemother 2005; 55: 888-896.
29. Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, Mor A, Friedman M, Steinberg D: Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob Agents Chemother 2008;52:638-642.
30. Belas R, Manos J, Suvanasuthi R: Proteus mi-rabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun 2004; 72: 5159-5167.
31. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J: Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus -derived proteinases. Antimicrob Agents Chemother 2004;48: 4673-4679.
32. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3: 710-720.
33. Lehrer RI: Primate defensins. Nat Rev Microbiol 2004;2:727-738.
34. Brogden KA: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3:238-250.
35. Yang D, Chertov O, Oppenheim JJ: The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cell Mol Life Sci 2001;58:978-989.